State Street
UTMD icon

State Street’s Utah Medical Products UTMD Stock Holding History

State Street’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.01M Sell
64,402
-3,605
-5% -$227K ﹤0.01% 3047
2025
Q4 		$3.83M Sell
68,007
-2,256
-3% -$131K ﹤0.01% 3109
2025
Q3 		$4.45M Buy
70,263
+141
+0.2% +$8.34K ﹤0.01% 3033
2025
Q2 		$4.01M Sell
70,122
-10,028
-13% -$545K ﹤0.01% 3036
2025
Q1 		$4.52M Sell
80,150
-2,548
-3% -$153K ﹤0.01% 2923
2024
Q4 		$5.11M Buy
82,698
+1,842
+2% +$119K ﹤0.01% 2966
2024
Q3 		$5.43M Buy
80,856
+694
+0.9% +$47.1K ﹤0.01% 2926
2024
Q2 		$5.38M Sell
80,162
-496
-0.6% -$33.8K ﹤0.01% 2897
2024
Q1 		$5.76M Buy
80,658
+6,331
+9% +$475K ﹤0.01% 2866
2023
Q4 		$6.28M Buy
74,327
+3,431
+5% +$285K ﹤0.01% 2846
2023
Q3 		$6.12M Sell
70,896
-20
-0% -$1.85K ﹤0.01% 2832
2023
Q2 		$6.63M Sell
70,916
-530
-0.7% -$49.9K ﹤0.01% 2860
2023
Q1 		$6.79M Buy
71,446
+1,421
+2% +$131K ﹤0.01% 2868
2022
Q4 		$7.06M Buy
70,025
+390
+0.6% +$35.6K ﹤0.01% 2879
2022
Q3 		$5.96M Sell
69,635
-368
-0.5% -$32.5K ﹤0.01% 2973
2022
Q2 		$6.03M Sell
70,003
-581
-0.8% -$49.6K ﹤0.01% 3002
2022
Q1 		$6.36M Buy
70,584
+1,650
+2% +$152K ﹤0.01% 3059
2021
Q4 		$6.89M Buy
68,934
+1,599
+2% +$163K ﹤0.01% 3096
2021
Q3 		$6.27M Buy
67,335
+1,282
+2% +$113K ﹤0.01% 3113
2021
Q2 		$5.64M Sell
66,053
-3,088
-4% -$267K ﹤0.01% 3189
2021
Q1 		$6.01M Sell
69,141
-8,235
-11% -$724K ﹤0.01% 2968
2020
Q4 		$6.54M Buy
77,376
+1,630
+2% +$139K ﹤0.01% 2830
2020
Q3 		$6.07M Sell
75,746
-1,041
-1% -$86.4K ﹤0.01% 2688
2020
Q2 		$6.83M Buy
76,787
+1,008
+1% +$90.5K ﹤0.01% 2614
2020
Q1 		$7.15M Sell
75,779
-1,942
-2% -$180K ﹤0.01% 2460
2019
Q4 		$8.41M Buy
77,721
+3,716
+5% +$376K ﹤0.01% 2609
2019
Q3 		$7.11M Buy
74,005
+1,878
+3% +$175K ﹤0.01% 2622
2019
Q2 		$6.92M Sell
72,127
-552
-0.8% -$46.5K ﹤0.01% 2659
2019
Q1 		$6.43M Sell
72,679
-22,938
-24% -$2.02M ﹤0.01% 2641
2018
Q4 		$7.97M Sell
95,617
-498
-0.5% -$43.8K ﹤0.01% 2528
2018
Q3 		$9.05M Buy
96,115
+4,928
+5% +$471K ﹤0.01% 2594
2018
Q2 		$10M Buy
91,187
+2,429
+3% +$254K ﹤0.01% 2539
2018
Q1 		$8.78M Sell
88,758
-439
-0.5% -$39.2K ﹤0.01% 2524
2017
Q4 		$7.26M Buy
89,197
+411
+0.5% +$32.1K ﹤0.01% 2625
2017
Q3 		$6.53M Buy
88,786
+9,404
+12% +$676K ﹤0.01% 2661
2017
Q2 		$5.75M Buy
79,382
+6,925
+10% +$456K ﹤0.01% 2671
2017
Q1 		$4.51M Sell
72,457
-1,159
-2% -$73K ﹤0.01% 2757
2016
Q4 		$5.36M Buy
73,616
+5,204
+8% +$338K ﹤0.01% 2659
2016
Q3 		$4.09M Buy
68,412
+2,796
+4% +$178K ﹤0.01% 2671
2016
Q2 		$4.13M Buy
65,616
+6,110
+10% +$394K ﹤0.01% 2702
2016
Q1 		$3.72M Buy
59,506
+4,855
+9% +$286K ﹤0.01% 2711
2015
Q4 		$3.2M Buy
54,651
+3,993
+8% +$226K ﹤0.01% 2778
2015
Q3 		$2.73M Buy
50,658
+2,399
+5% +$131K ﹤0.01% 2852
2015
Q2 		$2.88M Buy
48,259
+422
+0.9% +$23.8K ﹤0.01% 2915
2015
Q1 		$2.87M Buy
47,837
+815
+2% +$47.9K ﹤0.01% 2874
2014
Q4 		$2.82M Buy
47,022
+1,205
+3% +$66.7K ﹤0.01% 2887
2014
Q3 		$2.24M Buy
45,817
+301
+0.7% +$15.3K ﹤0.01% 2964
2014
Q2 		$2.34M Buy
45,516
+65
+0.1% +$3.34K ﹤0.01% 2994
2014
Q1 		$2.63M Buy
45,451
+228
+0.5% +$12.4K ﹤0.01% 2932
2013
Q4 		$2.58M Sell
45,223
-1,142
-2% -$62.7K ﹤0.01% 2944
2013
Q3 		$2.76M Buy
46,365
+655
+1% +$35.7K ﹤0.01% 2882
2013
Q2 		$2.48M Buy
+45,710
New +$2.15M ﹤0.01% 2860

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street's UTMD Position: Q1 2026 in Review

State Street reduced its Utah Medical Products (UTMD) stake by 5.3% in Q1 2026, selling an estimated $227K and leaving 64,402 shares worth $4.01M. The position accounts for ﹤0.01% of the portfolio, ranked #3047.

State Street first reported a position in UTMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $10M in Q2 2018. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • State Street held 64,402 shares of Utah Medical Products worth $4.01M as of Q1 2026.
  • State Street sold 3,605 Utah Medical Products shares in Q1 2026, an estimated $227K.
  • Utah Medical Products made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3047 holding.
  • State Street first reported a position in Utah Medical Products in Q2 2013 and has held it in 52 quarters since.
  • State Street's Utah Medical Products position peaked at $10M in Q2 2018.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.